KBXMF Stock UPDATES Kobex Minerals Inc. (KBXMF) 0.4990 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kobex Minerals Inc. (KBXMF) 0.4990 $KBXMF

Kobex Receives Conditional Approval for Change of Business to an Investment Issuer, and Sells Mineral Exploration Properties
Marketwire - Fri Aug 01, 4:01PM CDT
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) is pleased to announce that it has received conditional approval from the TSX Venture Exchange ("TSXV" for its proposed change of business ("Change of Business" to a Tier 1 investment issuer. Kobex intends to change its name to "Kobex Capital Corp." when its Change of Business is completed. The Company received shareholder approval for these changes at its annual and special general meeting (the "Meeting" held July 21, 2014. For more information regarding the Change of Business please refer to Kobex's news release of June 13, 2014 as well as the management information circular (the "Circular" prepared in respect of the Meeting, both of which are available at www.sedar.com.

IIROC Trade Resumption - Kobex Minerals Inc.
Newsfile Corp - Mon Jun 16, 7:32AM CDT
Trading resumes in:

Kobex Proposes Change of Business to an Investment Issuer and Sale of Mineral Exploration Properties
Marketwire - Fri Jun 13, 2:21PM CDT
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) is pleased to announce that it is proposing a change of business from a Mining Issuer to an Investment Issuer (the "Proposed COB" .

IIROC Trade Halt - Kobex Minerals Inc.
Newsfile Corp - Fri Jun 13, 1:05PM CDT
The following issues have been halted by IIROC:

Kobex Minerals Inc. Announces Intention to Terminate SEC Reporting Obligations
Marketwire - Wed Dec 18, 8:03AM CST
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) - today announces that it will voluntarily file a Form 15F with the United States Securities and Exchange Commission ("SEC" to terminate its SEC reporting obligations and the registration of its common shares under Section 12(g) the Securities Exchange Act of 1934, as amended (the "Exchange Act" .

Kobex Minerals Inc. Announces Normal Course Issuer Bid
Marketwire - Thu Dec 12, 5:28PM CST
Kobex Minerals Inc. ( "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) announced today that it has received regulatory approval from the TSX Venture Exchange (the "TSX Venture" to make a Normal Course Issuer Bid ("NCIB" commencing December 19, 2013 to purchase for cancellation up to 3,349,341 of its common shares, representing 10% of Kobex's public float (as defined by the TSX Venture) as at December 12, 2013. The maximum purchase price for the NCIB will be $0.60 per share, and the program will end on December 18, 2014 unless the maximum amount of common shares is purchased before then or Kobex provides earlier notice of termination.

Kobex Minerals Inc.: Grant of Options
Marketwire - Tue Sep 17, 4:54PM CDT
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) - announces that pursuant to the Company's Stock Option Plan, the Company has granted incentive stock options to two officers of the Company to purchase a total of 200,000 common shares at the exercise price of $0.55 each for a period of five years from the date of grant.

Kobex Minerals grants 1.4 million incentive stock options
M2 - Mon Jul 22, 6:27AM CDT
Kobex Minerals Inc (CDNX:KXM,V) (OTC:KBXMF), an exploration and development company, announced today, that under its stock option plan, it has granted incentive stock options to the directors and Philip du Toit, president and CEO of the company.

Kobex Minerals Inc.: Board of Directors and Officers
Marketwire - Wed Jul 10, 5:19PM CDT
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) - is pleased to announce that at the Annual General and Special Shareholders' meeting, which was held on July 8th, 2013, the following persons were elected to the board of directors: Michael Atkinson, E. Kenneth Paul, David Schmidt, A. Murray Sinclair and Paul van Eeden.

Kobex Minerals Announces Director and Executive Resignations
Marketwire - Fri Jun 14, 5:39PM CDT
Kobex Minerals Inc. (the "Company" or "Kobex" (TSX VENTURE: KXM)(OTCQB: KBXMF) announces the resignation of Mr. Jim O'Rourke as a Director. The Company also announces the resignation of Mr. Alfred Hills as President and Chief Executive Officer. As disclosed previously Mr. Hills has informed the Company he will not stand for re-election at the Company's upcoming annual general and special meeting to be held on July 8, 2013. Mr. Hills will continue as a Non-Executive Director of the Company until that date.

GRO, XIN, ASTC, KXM, GKNT, CDNS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Thu Jun 06, 5:02AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Agria Corp (NYSE:GRO), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN), Astrotech Corp (NASDAQ:ASTC), Kobex Minerals Inc (AMEX:KXM), Geeknet Inc (NASDAQ:GKNT), CADENCE DESIGN SYSTEMS, INC. (NASDAQ:CDNS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es